26 May 2026

strategyland.uk

Unilever PLC (ULVR)

Rank #63 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

Unilever PLC

ULVR.L·Consumer Non-Cyclicals·Market Cap £93.1b

Rank #63 of 100

Data from Excel Model · 100 Stocks Analysed

£42.55

-11.86% YTD

Target: £51.11(+20.1%)

52W: £36.48 - £55.26

Score Analysis

Unilever PLC is ranked #63 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

52/100

Average Score

Liquidity

Weak66/100

Valuation

Weak84/100

Profitability

Weak63/100

Solvency

Good37/100

Asset Efficiency

Fair55/100

Mkt Trading

Excellent2/100

Technical

Fair58/100

1. Valuation

Score: 84/100

Is ULVR undervalued compared to its peers and fair value metrics?

0/5

valuation criteria met

✗

FY26e P/E Ratio

15.4xRank 60/100

✗

FY27e P/E Ratio

14.5xRank 65/100

✗

Price-to-Book

7.83xRank 89/100

✗

Price-to-Tangible Book

N/ARank 101/100

✗

EV/EBITDA

12.4xRank 65/100

Key Valuation Metrics

Current P/E

19.1x

Price-to-Earnings

FY26e P/E

15.4x

Forward estimate

FY27e P/E

14.5x

Forward estimate

P/B Ratio

7.83x

Price-to-Book

P/TBV

N/A

Price-to-Tangible Book

EV/EBITDA

12.4x

Enterprise Value

FY26e EV/EBITDA

11.1x

Forward estimate

FY27e EV/EBITDA

11.1x

Forward estimate

Analyst Consensus Target

Current Price

£42.55

Consensus Target

£51.11

Potential

+20.1%

Target

Bloomberg Median Target: £51.50

2. Profitability

Score: 63/100

How profitable is ULVR relative to its peers?

0/6

profitability criteria met

✗

TTM Profit Margin

12.3%Rank 49/100

–

Current ROE

31.9%

–

Current ROA

N/A

✗

FY26e EPS

3.40Rank 77/100

–

TTM EPS

3.29

–

Net Income Growth

N/A

Profit Margin

12.3%

ROE

31.9%

FY27e ROE

44.7%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 37/100

How strong is ULVR's balance sheet and financial position?

1/4

solvency criteria met

–

Debt-to-Equity

156.9%

–

Interest Coverage

N/A

✓

Debt/EBITDA

Rank 39Rank 39/100

–

Altman Z-Score

1.78

Key Health Metrics

Quick Ratio

0.60

Below 1.0

Cash Ratio

0.79

Debt/Equity

157%

FCF Margin

2.6%

Altman Z-Score

1.78

Distress Zone

01.812.995+

4. Asset Efficiency

Score: 55/100

How efficiently does ULVR deploy its assets and intellectual capital?

1/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

✓

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

Rank 16/100

Overall Asset Efficiency Rank

Rank within sector peers#55/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.